Kera Capital Partners’s MetLife MET Stock Holding History

Kera Capital Partners’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,941	Closed	-$232K	–	600
2025 Q4	$232K	Buy	+2,941	New	+$233K	0.03%	488

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kera Capital Partners's MET Position: Q1 2026 in Review

Kera Capital Partners sold out of MetLife (MET) in Q1 2026, closing a stake of 2,941 shares — an estimated $232K sold.

Kera Capital Partners first reported a position in MET in Q4 2025 and held it in 1 quarter. The position peaked at $232K in Q4 2025. 1,377 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Kera Capital Partners reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Kera Capital Partners sold 2,941 MetLife shares in Q1 2026, an estimated $232K.
Kera Capital Partners first reported a position in MetLife in Q4 2025 and held it in 1 quarter.
Kera Capital Partners's MetLife position peaked at $232K in Q4 2025.
1,377 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Kera Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.